Research on SF-treated mouse cortical neurons and a triple-transgenic AD in vivo mouse model revealed increased expression of BDNF, potentially linked to SF’s ability to epigenetically enhance neuronal BDNF expression through histone acetylation and HDAC inhibition [177]. The gene discussed is HDAC9; the disease is Alzheimer disease.